Biochemical Engineering

Adendra Therapeutics launches with $53M series A raise

Adendra Therapeutics launches with $53M series A raise

7th December 2021

Apple Tree Partners has picked its first U.K.-based venture to launch: Adendra Therapeutics, an immunotherapy company focused on dendritic cell biology to treat cancers and autoimmune diseases. Adendra eked out $53 million in a series A financing to help with its launch. Source: Fierce Biotech 7/12/2021


Back to group news